Cargando…
In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519943/ https://www.ncbi.nlm.nih.gov/pubmed/34365560 http://dx.doi.org/10.1245/s10434-021-10572-3 |
_version_ | 1784584562160959488 |
---|---|
author | Thompson, John F. |
author_facet | Thompson, John F. |
author_sort | Thompson, John F. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8519943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-85199432021-10-29 In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? Thompson, John F. Ann Surg Oncol Melanoma Springer International Publishing 2021-08-07 2021 /pmc/articles/PMC8519943/ /pubmed/34365560 http://dx.doi.org/10.1245/s10434-021-10572-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Melanoma Thompson, John F. In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? |
title | In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? |
title_full | In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? |
title_fullStr | In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? |
title_full_unstemmed | In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? |
title_short | In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? |
title_sort | in sentinel node-positive melanoma patients, does omission of completion lymph node dissection make more intensive follow-up necessary, and does adjuvant systemic therapy permit less intensive follow-up? |
topic | Melanoma |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519943/ https://www.ncbi.nlm.nih.gov/pubmed/34365560 http://dx.doi.org/10.1245/s10434-021-10572-3 |
work_keys_str_mv | AT thompsonjohnf insentinelnodepositivemelanomapatientsdoesomissionofcompletionlymphnodedissectionmakemoreintensivefollowupnecessaryanddoesadjuvantsystemictherapypermitlessintensivefollowup |